UNSPSC 51283516: Oxacillin sodium

This classification denotes an anti-bacterial agent with the molecular formula C19H18N3O5S.Na.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G0V6C994Q5, chemically known as 5-methyl-3-phenyl-4-isoxazolyl penicillin, sodium but more generally known as oxacillin sodium, which bears US NIH Compound Identifier 4608. European Medicines Agency schedules Oxacillin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03559MIG.

Most nations, for tariff and trade purposes, schedule oxacillin sodium under HS 29411090 and SITC 54131. As of Q4 2014, OXACILLIN SODIUM remains US FDA's Preferred Term for this commodity. Oxacillin sodium bears US NLM identifiers UMLS ID C0037536 and NCI Concept Code C720. SMILES: CC1C(C(NO1)C2CCCCC2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-].O.[NA+].

UNSPSC 51283516 Oxacillin sodium is a Commodity code that nominally covers a specific antibiotic product, but recent state and local solicitations tagged with this code show no activity directly procuring oxacillin itself. Instead, the opportunities under this code reflect a broader scope of pharmaceutical and medical supply procurement by state health agencies, counties, and cities — including naloxone, generic multi-source pharmaceuticals, over-the-counter products, and emergency medical supplies. The actual buying activity encompasses competitive bidding for pharmaceutical products through authorized wholesalers, direct-to-manufacturer prescription initiatives, and shelf-stock medical supplies for first-responder use. Issuing bodies include state health and human services departments (Texas HHS Commission, Minnesota Department of Administration), county government (Seminole County, Florida), municipal purchasing offices (City of Tampa), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance / MMCAP) serving multi-state and multi-jurisdiction government buyers. No repeat solicitors appear across the recent opportunities, suggesting activity is geographically dispersed rather than concentrated in a single jurisdiction or agency type.

Recent activity spans Florida, Texas, Minnesota, and Oregon, with representation from both individual government entities and multi-state cooperative purchasing vehicles. Representative recent opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, with an estimated contract value of $700,000, designated as a sheltered market for certified Small Local Business Enterprises with a 5% bid discount; Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026) seeking vendor capabilities for a direct-to-manufacturer prescription program; and MMCAP's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products to be awarded to manufacturers and distributed through three authorized wholesalers starting July 1, 2026. The code shows no direct oxacillin procurement in the recent record.